{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "Pharmacologic Substance[C1909]|Biological Agent[C307]|Antineoplastic Biological Agent" in comments (approximate match)
Status:
Investigational
Source:
NCT02829099: Phase 1 Interventional Completed Advanced Solid Neoplasms
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00087022: Phase 3 Interventional Completed Kidney Cancer
(2004)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01802814: Phase 3 Interventional Completed Acute Lymphoblastic Leukemia (ALL)
(2014)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03193190: Phase 1/Phase 2 Interventional Active, not recruiting Pancreatic Adenocarcinoma
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01899599: Phase 2 Interventional Completed Ovarian Epithelial Cancer Recurrent
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02979899: Phase 3 Interventional Completed Advanced Angiosarcoma
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03411915: Phase 1 Interventional Completed Neuroendocrine Tumor
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03478488: Phase 3 Interventional Active, not recruiting Biliary Tract Neoplasms
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT04266301: Phase 3 Interventional Completed Myelodysplastic Syndromes
(2020)
Source URL:
Class:
PROTEIN